Contract Pharmacy Compliance: Navigating Recent Policy Changes
Stay current with evolving contract pharmacy requirements, manufacturer restrictions, and compliance strategies for multi-site 340B programs.
The Evolving Contract Pharmacy Landscape
Contract pharmacy arrangements have become increasingly complex due to manufacturer restrictions, policy changes, and compliance scrutiny. Covered entities must navigate these challenges while maintaining program integrity and maximizing patient access to affordable medications.
Manufacturer Restrictions
Many manufacturers have implemented restrictions limiting 340B contract pharmacy dispensing. These restrictions vary by manufacturer and may include limiting the number of contract pharmacies, requiring specific pharmacy types, or excluding contract pharmacies entirely. Covered entities must track manufacturer policies and adjust operations accordingly.
Compliance Requirements
- Written contract pharmacy agreements with clear responsibilities
- Oversight mechanisms and regular audits
- Duplicate discount prevention coordination
- Diversion control implementation and monitoring
- Claims data reporting and transparency
- Staff training and communication protocols
Oversight Best Practices
Effective contract pharmacy oversight requires clear agreements, regular audits, exception monitoring, and ongoing communication. Covered entities should conduct periodic on-site reviews, analyze dispensing data for anomalies, and ensure contract pharmacies maintain current policies and training. Documentation of oversight activities is essential for audit readiness.
Navigating Policy Uncertainty
Contract pharmacy policy continues to evolve through litigation, regulatory guidance, and legislative proposals. Covered entities should monitor developments, assess operational impacts, and adjust compliance frameworks proactively. CareBridge's Compliance Advisory Retainer provides ongoing policy monitoring and strategic guidance.